Respiratory failure & ventilation
Effect of a Lower Vs. Higher Positive End-Expiratory Pressure Strategy on Clinically Relevant Outcomes in ICU Patients Without Acute Respiratory Distress Syndrome: Bayesian Re-analysis of the REstricted Vs. Liberal Positive End-Expiratory Pressure in Patients Without Acute Respiratory Distress Syndrome (RELAx) Randomized Clinical Trial
Primary result · Higher VFD-28Result — go to the resultOdds ratio 1.08 95% CrI 0.87–1.35Authors' conclusion
Although the probability of benefit in the overall population was modest, the analysis suggested a higher probability of benefit in selected subgroups, particularly patients admitted for other reasons than cardiac arrest or intubated for other reasons than respiratory failure.
Study context
- Population
- Invasively ventilated ICU patients without Acute Respiratory Distress Syndrome (ARDS), expected to require ventilation ≥24 hours; 8 ICUs, October 2017–March 2019
- Participants
- 980 participants
- Comparison
- Lower positive end-expiratory pressures (PEEP) vs higher PEEP
- Primary endpoint
- Ventilator-free days at day 28 (VFD-28)
- Follow-up
- Day 28
Methodological detailsnon-inferiority, multicentre
- Non-inferiority
- Multicentre
Primary result
Higher VFD-28
Odds ratio
1.08
95% CrI 0.87–1.35
Lower PEEP vs Higher PEEP
OR 1.08 (95% CrI 0.87–1.35)
As reported in the abstract
- Probability of superiority of lower PEEP
- 75% to 78%
Secondary outcomes
28-day mortality
- Probability of benefit of lower PEEP
- 72% to 89%
Duration of ventilation
- Probability of benefit of lower PEEP
- 11% to 28%
Subgroups: admitted for reasons other than cardiac arrest or intubated for reasons other than respiratory failure (subgroup)
- Probabilities of benefit with lower PEEP exceeded 90%
Original publication
Effect of a Lower Vs. Higher Positive End-Expiratory Pressure Strategy on Clinically Relevant Outcomes in ICU Patients Without Acute Respiratory Distress Syndrome: Bayesian Re-analysis of the REstricted Vs. Liberal Positive End-Expiratory Pressure in Patients Without Acute Respiratory Distress Syndrome (RELAx) Randomized Clinical Trial. Crit Care Med. Published 31 March 2026. doi:10. 1097/ ccm. 0000000000007117
Composed by AI from the published abstract and checked against it. How Briefs are made →